Clinical Trials Directory

Trials / Conditions / Metastatic Hormone Receptor-Positive Breast Carcinoma

Metastatic Hormone Receptor-Positive Breast Carcinoma

7 registered clinical trials studyying Metastatic Hormone Receptor-Positive Breast Carcinoma — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingTesting the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-
NCT07137416
National Cancer Institute (NCI)Phase 1
RecruitingA Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Horm
NCT07112053
University of WashingtonPhase 2
WithdrawnTesting the Addition of an Investigational Anti-Cancer Drug, ASTX660 (Tolinapant), to a Usual Chemotherapy Tre
NCT06590558
National Cancer Institute (NCI)Phase 1
TerminatedTesting the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positiv
NCT05554354
National Cancer Institute (NCI)Phase 2
RecruitingFunctional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negat
NCT06179303
University of WashingtonPhase 2
RecruitingPersonalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positiv
NCT05098210
Fred Hutchinson Cancer CenterPhase 1
Active Not RecruitingTesting the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cance
NCT03939897
National Cancer Institute (NCI)Phase 1